The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Akhmadulina A.O.

Russian Medical Academy of Continuous Professional Education

Chimagomedova A.Sh.

Russian Medical Academy of Continuous Professional Education

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

Clinical phenomenology and pathophysiology of daytime and nighttime imperative movements

Authors:

Akhmadulina A.O., Chimagomedova A.Sh., Levin O.S., Poluektov M.G.

More about the authors

Read: 2371 times


To cite this article:

Akhmadulina AO, Chimagomedova ASh, Levin OS, Poluektov MG. Clinical phenomenology and pathophysiology of daytime and nighttime imperative movements. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11‑2):67‑72. (In Russ.)
https://doi.org/10.17116/jnevro202212211267

Recommended articles:
Effe­cts of rhythmic transcranial magnetic stimulation in the treatment of inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):64-69
Higher-level ambu­lation diso­rders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11-2):32-38
Clinical and instrumental diagnostics of facial neuropathy in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):31-36

References:

  1. Ekstrapiramidnye rasstrojstva: Rukovodstvo po diagnostike i lecheniyu. Shtok VN, Ivanova-Smolenskaya IA, Levin OS, eds. M.: MEDpress-inform; 2002:608. (In Russ.).
  2. Ferini-Strambi L. RLS-like symptoms: differential diagnosis by history and clinical assessment. Sleep Medicine. 2007;8(2):3-6.  https://doi.org/10.1016/j.sleep.2007.04.009
  3. Garcia-Borreguero D, Stillman P, Benes H, et al. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurology. 2011;11:28.  https://doi.org/10.1186/1471-2377-11-28
  4. Levin OS. Restless legs syndrome (Willis-Ekbom disease). M.: MEDpress-inform; 2015:96. (In Russ.).
  5. Garcia-Borreguero D, Kohnen R, Silber MH, et al. The long-term treatment of restless legs syndrome/Willis Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance:are port from the International Restless Legs Syndrome Study Group. Sleep Medicine. 2013;14:675-684.  https://doi.org/10.1016/j.sleep.2013.05.016
  6. Lohr JB, Eidt CA, Alfaraj AA, Soliman MA. The clinical challenges of akathisia. CNS Spectrum. 2015;20:4-14.  https://doi.org/10.1017/S1092852915000838
  7. Levin OS. Podkhody k diagnostike i lecheniyu sindroma bespokojnykh nog. Trudnyj patsient. April 2009. (In Russ.). Accessed November 30, 2021. https://t-pacient.ru/articles/6439
  8. Chokroverty S. Differential diagnoses of restless legs syndrome/Willis-Ekbom disease mimics and comorbidities. Sleep Med Clin. 2015;10:249-262.  https://doi.org/10.1016/j.jsmc.2015.05.021
  9. Fahn S, Jankovic J, Hallett M. Principles and Practice of Movement Disorders. 2nd ed. Edinburgh, New York: Elsevier/Saunders; 2011.
  10. Sachdev P. The development of the concept of akathisia: A historical overview. Schizophr Res. 1995;16(1):33-45.  https://doi.org/10.1016/0920-9964(94)00058-g
  11. Stacy M. Nonmotor symptoms in Parkinson’s disease. Int J Neurosci. 2011; 121(12):9-17.  https://doi.org/10.3109/00207454.2011.620196
  12. Madruga-Garrido M, Mir P. Tics and other stereotyped movements as side effects of pharmacological treatment. In: Davide M, Andrea EC, eds. International Review of Neurobiology. London: Academic Press; 2013:481-494. 
  13. Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016;76(7):759-777.  https://doi.org/10.1007/s40265-016-0566-3
  14. Maréchal E, Denoiseux B, Thys E, et al. Impulse control disorders in Parkinson’s disease: An overview from neurobiology to treatment. J Neurol. 2015;262:7-20.  https://doi.org/10.1007/s00415-014-7361-4
  15. Maloney EM, Djamshidian A, O’Sullivan SS. Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson’s disease, atypical Parkinsonian disorders and non-Parkinsonian populations. J Neurol Sci. 2017;374:47-52.  https://doi.org/10.1016/j.jns.2016.12.058
  16. Sierra M, Carnicella S, Strafella AP, et al. Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors. J Parkinsons Dis. 2015;5(3):625-636.  https://doi.org/10.3233/JPD-150535
  17. Antonini A, Chaudhuri KR, Boroojerdi B, et al. Impulse control disorder related behaviours during long-term rotigotine treatment: A post hoc analysis. European Journal of Neurology. 2016;23(10):1556-1565. https://doi.org/10.1111/ene.13078
  18. Zhang G, Zhang Z, Liu L, et al. Impulsive and compulsive behaviors in Parkinson’s disease. Front Aging Neuroscience. 2014;6:318.  https://doi.org/10.3389/fnagi.2014.00318
  19. Bhalsing K, Suresh K, Muthane UB, Pal PKr. Prevalence and profile of Restless Legs Syndrome in Parkinson’s disease and other neurodegenerative disorders: A case-control study. Parkinsonism & Related Disoders. 2013;19:426-430.  https://doi.org/10.1016/j.parkreldis.2012.12.005
  20. Marchesi E, Negrotti A, Angelini M, et al. A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson’s disease during chronic dopaminergic therapy. J Neurol. 2016;263(3):441-447.  https://doi.org/10.1007/s00415-015-7937-7
  21. Warren Olanow C, Kieburtz K, Rascol O, et al. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson’s disease. Mov Disord. 2013;28:1064-1071. https://doi.org/10.1002/mds.25364
  22. Manconi M, Ulfberg J, Berger K, et al. When gender matters: restless legs syndrome. Report of the «RLS and woman» workshop endorsed by the European RLS Study Group. Sleep Med Rev. 2012;16:297-307.  https://doi.org/10.1016/j.smrv.2011.08.006
  23. Valenca G, Glass P, Negreiros N, et al. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson’s disease. Parkinsonism & Related Disorders. 2013;19(7):698-700.  https://doi.org/10.1016/j.parkreldis.2013.03.004
  24. Voon V, Sohr M, Lang A, et al. Impulse control disorders in Parkinson disease: A multicenter case-control study. Annals of Neurology. 2011;69:986-996.  https://doi.org/10.1002/ana.22356
  25. Arabia G, Zappia M, Bosco D, et al. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson’s disease. Neurol Sci. 2002;23(2):53-54.  https://doi.org/10.1007/s100720200066
  26. Callesen M, Weintraub D, Damholdt M, Moller A. Impulsive and compulsive behaviors among Danish patients with Parkinson’s disease: Prevalence, depression, and personality. Parkinsonism & Related Disorders. 2014;20(1):22-26.  https://doi.org/10.1016/j.parkreldis.2013.09.006
  27. Phu A, Xu Z, Brakoulias V, et al. Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients. Journal of Clinical Neuroscience. 2014;21(1):63-66.  https://doi.org/10.1016/j.jocn.2013.02.032
  28. Hurt C, Alkufri F, Brown R, et al. Motor phenotypes, medication and mood: Further associations with impulsive behaviours in Parkinson’s disease. Journal of Parkinson’s Disease. 2013;4:245-254.  https://doi.org/10.3233/JPD-130314
  29. Zhang YH, Tang BS, Song CY, et al. The relationship between the phenotype of Parkinson’s disease and levodopa-induced dyskinesia. Neurosci Lett. 2013;556:109-112.  https://doi.org/10.1016/j.neulet.2013.10.018
  30. Ferré S, Bonaventura J, Zhu W, et al. Essential control of the function of the striatopallidal neuron by pre-coupled complexes of adenosine A2A-dopamine D2 receptor heterotetramers and adenylyl cyclase. Front Pharmacol. 2018;9:243.  https://doi.org/10.3389/fphar.2018.00243
  31. Ferré S, Quiroz C, Guitart X, et al. Pivotal role of adenosine neurotransmission in restless legs syndrome. Front Neurosci. 2018;11:722.  https://doi.org/10.3389/fnins.2017.00722
  32. Nash JE, Brotchie JM. A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson’s disease. J Neurosci. 2000;20:7782-7789. https://doi.org/10.1523/JNEUROSCI.20-20-07782.2000
  33. Gupta R, Ali R, Ray R. Willis-Ekbom disease/restless legs syndrome in patients with opioid withdrawal. Sleep Med. 2018;45:39-43.  https://doi.org/10.1016/j.sleep.2017.09.028

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.